Crossmark

Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study

Crossref DOI link: https://doi.org/10.1038/s41409-021-01291-0

Published Online: 2021-04-19

Published Print: 2021-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Inoue, Yoshitaka https://orcid.org/0000-0002-3967-7356
Okinaka, Keiji

Fuji, Shigeo

Inamoto, Yoshihiro https://orcid.org/0000-0003-4881-0427
Uchida, Naoyuki https://orcid.org/0000-0001-5952-5926
Toya, Takashi https://orcid.org/0000-0002-7436-972X
Ikegame, Kazuhiro https://orcid.org/0000-0002-5421-7470
Eto, Tetsuya

Ozawa, Yukiyasu

Iwato, Koji

Kanda, Yoshinobu https://orcid.org/0000-0002-4866-9307
Atsuta, Yoshiko https://orcid.org/0000-0003-4404-2870
Ogata, Masao https://orcid.org/0000-0002-4896-5878
Fukuda, Takahiro

,
Funding

Funding for this research was provided by:

The National Cancer Center Research and Development Fund
License Information

Text and Data Mining valid from 2021-04-19

Version of Record valid from 2021-04-19
More Information

Article History

Received: 10 June 2020

Revised: 11 March 2021

Accepted: 29 March 2021

First Online: 19 April 2021

Compliance with ethical standards

:

: YA reports Honoraria (e.g., lecture fees) from Chugai Pharmaceutical Co. Ltd, Kyowa Kirin Co., Ltd, Bristol-Myers Squibb Co., Ltd, Yakult Honsha Co., Ltd., Janssen Pharmaceutical K.K., and Otsuka Pharmaceutical Co., Ltd, outside the submitted work. The other authors declare no competing interests associated with this paper.

Document is current

Any future updates will be listed below